 | • レポートコード：TPM-DJ143 • 出版社/出版日：Transparency Market Research / 2019年3月15日 • レポート形態：英文、PDF、172ページ • 納品方法：Eメール • 産業分類：製薬 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、脱毛症の多血小板血漿治療および幹細胞治療の世界市場について調べ、脱毛症の多血小板血漿治療および幹細胞治療の市場規模、市場動向、市場シェア、市場環境、市場予測、関連企業情報などをまとめました。 |
Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market: Overview
This report analyzes the current and future scenario of the global platelet rich plasma & stem cell alopecia treatment market for the period 2018 to 2026. Rise in awareness about platelet rich plasma therapies and stem cell therapies, increase in funding for alopecia treatment research and stem cell research, and increase in the incidence of autoimmune hair loss disorders are likely to be major drivers of the global platelet rich plasma & stem cell alopecia treatment market during the forecast period.
The global platelet rich plasma & stem cell alopecia treatment market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on treatment, indication, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises a competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides presence of key players working in the development of stem cell and platelet rich pharmaceutical products, thereby presenting a thorough analysis of the overall competitive scenario in the global platelet rich plasma & stem cell alopecia treatment market.
Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market: Key Segments
Based on treatment, the global platelet rich plasma & stem cell alopecia treatment market has been segmented into platelet rich plasma therapy and stem cell therapy. The stem cell therapy segment has been further classified into bone marrow treatment and adipose treatment. In terms of indication, the global platelet rich plasma & stem cell alopecia treatment market has been classified into androgenic alopecia, congenital alopecia, cicatricial or scarring alopecia and others. Based on end-user, the global platelet rich plasma & stem cell alopecia treatment market has been divided into hospitals, dermatology clinics, and others. The market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year.
Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market: Regional Outlook
In terms of region, the global platelet rich plasma & stem cell alopecia treatment market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in the Report
The report also profiles major players operating in the global platelet rich plasma & stem cell alopecia treatment market based on various attributes, such as company overview, financial overview, pipeline portfolio, product portfolio, business strategies, and recent developments. The players covered in the report include Kerastem, Eclipse, Regen Lab SA, Stemcell Technologies, Inc., RepliCel Life Sciences, Histogen, Inc., and Glofinn Oy.
The global platelet rich plasma & stem cell alopecia treatment market has been segmented as below:
Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market, by Treatment
Platelet Rich Plasma Therapies
Stem Cell Therapy
Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market, by Indication
Androgenic Alopecia
Congenital Alopecia
Cicatricial or Scarring Alopecia
Others
Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market, by End-user
Hospitals
Dermatology Clinics
Others
Global Platelet Rich Plasma & Stem Cell Alopecia Treatment , by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Treatment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecasts, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Analysis of Treatments for Alopecia: Overview
5.2. Top Treatment Center Analysis, by Region
5.3. Platelet Rich Plasma & Stem Cell Alopecia Treatment Market: Pipeline Analysis – 2018
6. Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecasts, by Treatment
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Treatment, 2016–2026
6.3.1. Platelet Rich Plasma Therapies
6.3.2. Stem Cell Therapy
6.3.2.1. Bone Marrow
6.3.2.2. Adipose
6.4. Market Attractiveness, by Treatment
7. Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecasts, by Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Indication, 2016–2026
7.3.1. Androgenic Alopecia
7.3.2. Congenital Alopecia
7.3.3. Cicatricial or Scarring Alopecia
7.3.4. Others
7.4. Market Attractiveness, by Indication
8. Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecasts, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2016–2026
8.3.1. Hospitals
8.3.2. Dermatology Clinics
8.3.3. Others
8.4. Market Attractiveness, by End-user
9. Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region
10. North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Treatment, 2016–2026
10.2.1. Platelet Rich Plasma Therapies
10.2.2. Stem Cell Therapy
10.2.2.1. Bone Marrow
10.2.2.2. Adipose
10.3. Market Value Forecast, by Indication, 2016–2026
10.3.1. Androgenic Alopecia
10.3.2. Congenital Alopecia
10.3.3. Cicatricial or Scarring Alopecia
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2016–2026
10.4.1. Hospitals
10.4.2. Dermatology Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country, 2016–2026
10.5.1. US
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Treatment
10.6.2. By Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Treatment, 2016–2026
11.2.1. Platelet rich plasma therapies
11.2.2. Stem Cell Therapy
11.2.2.1. Bone Marrow
11.2.2.2. Adipose
11.3. Market Value Forecast, by Indication, 2016–2026
11.3.1. Androgenic Alopecia
11.3.2. Congenital Alopecia
11.3.3. Cicatricial or Scarring Alopecia
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2016–2026
11.4.1. Hospitals
11.4.2. Dermatology Clinics
11.4.3. Others
11.5. Market Value Forecast, by Country, 2016–2026
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Treatment
11.6.2. By Indication
11.6.3. By End-user
11.6.4. By Country
12. Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Treatment, 2016–2026
12.2.1. Platelet rich plasma therapies
12.2.2. Stem Cell Therapy
12.2.2.1. Bone Marrow
12.2.2.2. Adipose
12.3. Market Value Forecast, by Indication, 2016–2026
12.3.1. Androgenic Alopecia
12.3.2. Congenital Alopecia
12.3.3. Cicatricial or Scarring Alopecia
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2016–2026
12.4.1. Hospitals
12.4.2. Dermatology Clinics
12.4.3. Others
12.5. Market Value Forecast, by Country, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Austalia & New Zearland
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Treatment
12.6.2. By Indication
12.6.3. By End-user
12.6.4. By Country
13. Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Treatment, 2016–2026
13.2.1. Platelet rich plasma therapies
13.2.2. Stem Cell Therapy
13.2.2.1. Bone Marrow
13.2.2.2. Adipose
13.3. Market Value Forecast, by Indication, 2016–2026
13.3.1. Androgenic Alopecia
13.3.2. Congenital Alopecia
13.3.3. Cicatricial or Scarring Alopecia
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2016–2026
13.4.1. Hospitals
13.4.2. Dermatology Clinics
13.4.3. Others
13.5. Market Value Forecast, by Country, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
3.6. Market Attractiveness Analysis
13.6.1. By Treatment
13.6.2. By Indication
13.6.3. By End-user
13.6.4. By Country
14. Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Treatment, 2016–2026
14.2.1. Platelet rich plasma therapies
14.2.2. Stem Cell Therapy
14.2.2.1. Bone Marrow
14.2.2.2. Adipose
14.3. Market Value Forecast, by Indication, 2016–2026
14.3.1. Androgenic Alopecia
14.3.2. Congenital Alopecia
14.3.3. Cicatricial or Scarring Alopecia
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2016–2026
14.4.1. Hospitals
14.4.2. Dermatology Clinics
14.4.3. Others
14.5. Market Value Forecast, by Country, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Treatment
14.6.2. By Indication
14.6.3. By End-user
14.6.4. By Country
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Heat Map Analysis, by Company (2017)
15.3. Company Profiles
15.3.1. Kerastem
15.3.2. Eclipse
15.3.3. Regen Lab SA
15.3.4. Restore Hair
15.3.5. Replicel LifeScience
15.3.6. Histogen Inc.
15.3.7. Glofinn Oy
Table 01: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Treatment, 2016–2026
Table 02: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Value (US$ Mn) Forecast, Treatment (Stem Cell Therapy), 2016–2026
Table 03: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Indication, 2016–2026
Table 04: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 05: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 07: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Treatment, 2016–2026
Table 08: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment for Stem Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 09: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Indication, 2016–2026
Table 10: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Treatment, 2016–2026
Table 13: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment for Stem Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 14: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Indication, 2016–2026
Table 15: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 16: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Treatment, 2016–2026
Table 18: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment for Stem Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 19: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Indication, 2016–2026
Table 20: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 21: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Treatment, 2016–2026
Table 23: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment for Stem Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 24: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Indication, 2016–2026
Table 25: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 26: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 27: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Treatment, 2016–2026
Table 28: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment for Stem Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 29: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Indication, 2016–2026
Table 30: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026